Observational studyClinical and experimental nephrology2026
Risk analysis and nomogram-based prediction for Double-J stent encrustation: accounting for chronic kidney disease.
Observational study in Clinical and experimental nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDouble J (DJ) stent encrustation is a common postoperative complication that can lead to severe infection, obstruction, or stent retention. Existing predictive models primarily focus on indwelling time and urinary pH but have largely excluded patients with chronic kidney disease (CKD), limiting their applicability. This multicenter study aimed to develop and externally validate a nomogram for individualized prediction of DJ stent encrustation, incorporating renal function status for the first time.
methodsA total of 760 patients who underwent upper urinary tract stone surgery with postoperative DJ stent placement were retrospectively analyzed. Clinical, biochemical, and behavioral variables were evaluated. Multivariate logistic regression identified independent predictors, which were used to construct a predictive nomogram. External validation was performed using an independent cohort of 337 patients from another tertiary hospital. Model discrimination, calibration, and clinical benefit were assessed by receiver operating characteristic (ROC) curve analysis, bootstrap calibration, and decision curve analysis (DCA).
resultsStent encrustation occurred in 121 patients (15.9%). Four variables-stent indwelling time, urine pH, daily water intake, and renal function stage-were independently associated with encrustation (p < 0.05 for all). The nomogram achieved excellent discrimination (AUC = 0.877) and maintained strong external performance (AUC = 0.884). CKD significantly increased risk in a dose-dependent manner, and interaction analysis revealed a synergistic effect between CKD and urine pH (p = 0.002), explaining the lack of independent significance of pH in CKD subgroups.
conclusionThis study established and externally validated the first nomogram for predicting DJ stent encrustation that includes CKD as a systemic variable. The model demonstrates high accuracy and generalizability, offering a practical tool for early identification of high-risk patients, particularly those with renal impairment, to guide individualized stent management and prevent irreversible renal damage.
Indexed as
Identifiers
41733780What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.